Literature DB >> 33891778

Image Quality Assessment of Fetal Brain MRI Using Multi-Instance Deep Learning Methods.

Axel Largent1, Kushal Kapse1, Scott D Barnett1, Josepheen De Asis-Cruz1, Matthew Whitehead1,2, Jonathan Murnick1, Li Zhao1, Nicole Andersen1, Jessica Quistorff1, Catherine Lopez1, Catherine Limperopoulos1,3,4.   

Abstract

BACKGROUND: Due to random motion of fetuses and maternal respirations, image quality of fetal brain MRIs varies considerably. To address this issue, visual inspection of the images is performed during acquisition phase and after 3D-reconstruction, and the images are re-acquired if they are deemed to be of insufficient quality. However, this process is time-consuming and subjective. Multi-instance (MI) deep learning methods (DLMs) may perform this task automatically.
PURPOSE: To propose an MI count-based DLM (MI-CB-DLM), an MI vote-based DLM (MI-VB-DLM), and an MI feature-embedding DLM (MI-FE-DLM) for automatic assessment of 3D fetal-brain MR image quality. To quantify influence of fetal gestational age (GA) on DLM performance. STUDY TYPE: Retrospective.
SUBJECTS: Two hundred and seventy-one MR exams from 211 fetuses (mean GA ± SD = 30.9 ± 5.5 weeks). FIELD STRENGTH/SEQUENCE: T2 -weighted single-shot fast spin-echo acquired at 1.5 T. ASSESSMENT: The T2 -weighted images were reconstructed in 3D. Then, two fetal neuroradiologists, a clinical neuroscientist, and a fetal MRI technician independently labeled the reconstructed images as 1 or 0 based on image quality (1 = high; 0 = low). These labels were fused and served as ground truth. The proposed DLMs were trained and evaluated using three repeated 10-fold cross-validations (training and validation sets of 244 and 27 scans). To quantify GA influence, this variable was included as an input of the DLMs. STATISTICAL TESTS: DLM performance was evaluated using precision, recall, F-score, accuracy, and AUC values.
RESULTS: Precision, recall, F-score, accuracy, and AUC averaged over the three cross validations were 0.85 ± 0.01, 0.85 ± 0.01, 0.85 ± 0.01, 0.85 ± 0.01, 0.93 ± 0.01, for MI-CB-DLM (without GA); 0.75 ± 0.03, 0.75 ± 0.03, 0.75 ± 0.03, 0.75 ± 0.03, 0.81 ± 0.03, for MI-VB-DLM (without GA); 0.81 ± 0.01, 0.81 ± 0.01, 0.81 ± 0.01, 0.81 ± 0.01, 0.89 ± 0.01, for MI-FE-DLM (without GA); and 0.86 ± 0.01, 0.86 ± 0.01, 0.86 ± 0.01, 0.86 ± 0.01, 0.93 ± 0.01, for MI-CB-DLM with GA. DATA
CONCLUSION: MI-CB-DLM performed better than other DLMs. Including GA as an input of MI-CB-DLM improved its performance. MI-CB-DLM may potentially be used to objectively and rapidly assess fetal MR image quality. EVIDENCE LEVEL: 4 TECHNICAL EFFICACY: Stage 3.
© 2021 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  deep learning; fetal brain MRI; image quality assessment; multi-instance learning; weakly supervised learning

Year:  2021        PMID: 33891778     DOI: 10.1002/jmri.27649

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  4 in total

1.  Artifact- and content-specific quality assessment for MRI with image rulers.

Authors:  Ke Lei; Ali B Syed; Xucheng Zhu; John M Pauly; Shreyas S Vasanawala
Journal:  Med Image Anal       Date:  2022-01-20       Impact factor: 8.545

2.  A Brief Survey on No-Reference Image Quality Assessment Methods for Magnetic Resonance Images.

Authors:  Igor Stępień; Mariusz Oszust
Journal:  J Imaging       Date:  2022-06-04

3.  Automatic brain segmentation in preterm infants with post-hemorrhagic hydrocephalus using 3D Bayesian U-Net.

Authors:  Axel Largent; Josepheen De Asis-Cruz; Kushal Kapse; Scott D Barnett; Jonathan Murnick; Sudeepta Basu; Nicole Andersen; Stephanie Norman; Nickie Andescavage; Catherine Limperopoulos
Journal:  Hum Brain Mapp       Date:  2022-01-13       Impact factor: 5.038

4.  An Internet-of-Disease System for COVID-19 Testing Using Saliva by an AI-Controlled Microfluidic ELISA Device.

Authors:  Nabil Hossain Bhuiyan; Md Jalal Uddin; Joowon Lee; Jun Hyeok Hong; Joon Sub Shim
Journal:  Adv Mater Technol       Date:  2022-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.